menu
    • menu

    Company profile for Stalicla

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    STALICLA is a patient-centric biotech company on a unique mission to identify, develop and bring precision medicine to patients with neurodevelopmental disorders, with a first application in autism spectrum disorder. STALICLA has assembled a world-class team of experienced drug developers, clinicians and computational systems biologists. DEPI, the company's unique technology characterizes biologically similar subgroups of pa...
    STALICLA is a patient-centric biotech company on a unique mission to identify, develop and bring precision medicine to patients with neurodevelopmental disorders, with a first application in autism spectrum disorder. STALICLA has assembled a world-class team of experienced drug developers, clinicians and computational systems biologists. DEPI, the company's unique technology characterizes biologically similar subgroups of patients within highly variable populations of patients with neurodevelopmental disorders, and further identifies tailored treatments. To support its drug discovery platform and pipeline development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    StaliclaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Campus Biotech Innovation Park Avenue de Secheron 15 1202 Genève
    Telephone
    Telephone
    + 41 22 545 12 42
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://stalicla.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Addex Leads CHF 2M Investment in Stalicla for Precision Medicine
    Addex Leads CHF 2M Investment in Stalicla for Precision Medicine

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107133/0/en/Addex-Leads-CHF-2-Million-Investment-in-Stalicla-to-Advance-Precision-Medicine-in-Neuropsychiatric-Disorders.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share
    Dr. Paulo Fontoura Joins STALICLA As Development Advisor
    Dr. Paulo Fontoura Joins STALICLA As Development Advisor

    19 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/19/2948879/0/en/Dr-Paulo-Fontoura-MD-PhD-joins-STALICLA-as-Chief-Scientific-and-Clinical-Development-Advisor.html

    GLOBENEWSWIRE
    19 Sep 2024
    Share Share
    STALICLA appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors
    STALICLA appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors

    09 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/07/09/2910211/0/en/STALICLA-appoints-Dr-Purnanand-Sarma-PhD-as-Chair-of-the-Board-of-Directors.html

    GLOBENEWSWIRE
    09 Jul 2024
    Share Share
    STALICLA publishes pioneering phase 1b data on precision treatment
    STALICLA publishes pioneering phase 1b data on precision treatment

    27 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/27/2905078/0/en/STALICLA-publishes-pioneering-phase-1b-data-on-precision-treatment-for-autism-spectrum-disorder-in-Biomedicines.html

    GLOBENEWSWIRE
    27 Jun 2024
    Share Share
    STALICLA Initiates US DDI Study Of STP7 For Cocaine Use Disorder
    STALICLA Initiates US DDI Study Of STP7 For Cocaine Use Disorder

    02 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/02/2874183/0/en/STALICLA-initiates-U-S-Phase-3-enabling-DDI-study-of-STP7-Mavoglurant-to-treat-cocaine-use-disorder.html

    GLOBENEWSWIRE
    02 May 2024
    Share Share
    STALICLA Appoints Dr. Thomas Blaettler, MD
    STALICLA Appoints Dr. Thomas Blaettler, MD

    11 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240411118139/en

    BUSINESSWIRE
    11 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search